V
Vibeke Lind Jørgensen
Researcher at University of Copenhagen
Publications - 28
Citations - 764
Vibeke Lind Jørgensen is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 9, co-authored 18 publications receiving 368 citations. Previous affiliations of Vibeke Lind Jørgensen include Copenhagen University Hospital & Herlev Hospital.
Papers
More filters
Journal ArticleDOI
Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis.
Lars Andresen,Vibeke Lind Jørgensen,Anders Perner,A Hansen,Jesper Eugen-Olsen,Jørgen Rask-Madsen +5 more
TL;DR: The results suggest that downstream inflammatory reactions leading to tissue damage originate in lamina propria immune cells, as increased NFκB activity in collagenous colitis was localised solely in epithelial cells, but present also in macrophages in ulcerative colitis.
Journal ArticleDOI
Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial.
Marie Warrer Munch,Sheila Nainan Myatra,Bharath Kumar Tirupakuzhi Vijayaraghavan,Sanjith Saseedharan,Thomas Benfield,Rebecka Rubenson Wahlin,Bodil Steen Rasmussen,Anne Sofie Andreasen,Lone Musaeus Poulsen,Luca Cioccari,Mohd Saif Khan,Farhad N Kapadia,Jigeeshu V Divatia,Anne Craveiro Brøchner,Morten H. Bestle,Marie Helleberg,Jens Michelsen,Ajay Padmanaban,Neeta Bose,Anders Pape Møller,Kapil Borawake,Klaus Tjelle Kristiansen,Urvi Shukla,Michelle S Chew,Subhal Dixit,Charlotte Suppli Ulrik,Pravin Amin,Rajesh Chawla,Christian A Wamberg,Mehul S Shah,Iben S Darfelt,Vibeke Lind Jørgensen,Margit Smitt,Anders Granholm,Maj-Brit Nørregaard Kjaer,Morten Hylander Møller,Tine Sylvest Meyhoff,Gitte Kingo Vesterlund,Naomi E Hammond,Naomi E Hammond,Sharon Micallef,Abhinav Bassi,Oommen John,Oommen John,Anubhuti Jha,Maria Cronhjort,Stephan M. Jakob,Christian Gluud,Christian Gluud,Theis Lange,Vaijayanti Kadam,Klaus Marcussen,Jacob Hollenberg +52 more
TL;DR: In this article, the effects of 12 mg vs 6 mg/d of dexamethasone in patients with COVID-19 and severe hypoxemia were evaluated in a randomized clinical trial at 26 hospitals in Europe and India.
Journal ArticleDOI
Characteristics, interventions and longer-term outcomes of COVID-19 ICU patients in Denmark - a nationwide, observational study.
Nicolai Haase,Ronni Plovsing,Steffen Christensen,Lone Musaeus Poulsen,Anne Craveiro Brøchner,Bodil Steen Rasmussen,Marie Helleberg,Jens-Ulrik Stæhr Jensen,Lars Peter Kloster Andersen,Hanna Siegel,Michael Ibsen,Vibeke Lind Jørgensen,Robert Winding,Susanne Iversen,Henrik Pedersen,Jacob Madsen,Christoffer Sølling,Ricardo Sanchez Garcia,Jens Michelsen,Thomas Mohr,Anne Mannering,Ulrick Skipper Espelund,Helle Bundgaard,Lynge Kirkegaard,Margit Smitt,David Levarett Buck,Niels Erik Ribergaard,Helle B.S. Pedersen,Birgitte V. Christensen,Anders Perner +29 more
TL;DR: Characteristics, interventions and longer term outcomes of the entire, unselected cohort of all ICU patients with COVID‐19 in Denmark where the ICU capacity was not exceeded are presented.
Journal ArticleDOI
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial.
Anders Granholm,Marie Warrer Munch,Sheila Nainan Myatra,Bharath Kumar Tirupakuzhi Vijayaraghavan,Bharath Kumar Tirupakuzhi Vijayaraghavan,Maria Cronhjort,Rebecka Rubenson Wahlin,Stephan M. Jakob,Luca Cioccari,Maj Brit Nørregaard Kjær,Gitte Kingo Vesterlund,Tine Sylvest Meyhoff,Marie Helleberg,Morten Hylander Møller,Thomas Benfield,Balasubramanian Venkatesh,Naomi E Hammond,Naomi E Hammond,Naomi E Hammond,Sharon Micallef,Abhinav Bassi,Oommen John,Oommen John,Vivekanand Jha,Vivekanand Jha,Vivekanand Jha,Klaus Tjelle Kristiansen,Charlotte Suppli Ulrik,Vibeke Lind Jørgensen,Margit Smitt,Morten H. Bestle,Morten H. Bestle,Anne Sofie Andreasen,Lone Musaeus Poulsen,Bodil Steen Rasmussen,Anne Craveiro Brøchner,Thomas Strøm,Anders Pape Møller,Mohd Saif Khan,Ajay Padmanaban,Jigeeshu V Divatia,Sanjith Saseedharan,Kapil Borawake,Farhad N Kapadia,Subhal Dixit,Rajesh Chawla,Urvi Shukla,Pravin Amin,Michelle S Chew,Christian Aage Wamberg,Christian Gluud,Christian Gluud,Theis Lange,Anders Perner +53 more
TL;DR: In this article, the authors compared dexamethasone 12 versus 6mg daily for up to 10 days in patients with coronavirus disease 2019 (COVID-19) and severe hypoxaemia in the international, randomised, blinded COVID STEROID 2 trial.
Journal ArticleDOI
Increased colorectal permeability in patients with severe sepsis and septic shock
TL;DR: In septic patients, the systemic recovery of a luminally applied marker of paracellular permeability was increased and related to the luminal concentrations of L-lactate and possibly to disease severity, suggesting that metabolic dysfunction of the mucosa contributes to increased permeability of the large bowel in patients with severe sepsis and septic shock.